Mice of the RIIIS/J inbred strain have prolonged bleeding times (>15 minutes) after experimental injury when compared with normal C57BL/6J mice (1.8 minutes) and other strains of mice. The prolonged bleeding time was accompanied by normal platelet counts. Platelet aggregation with collagen and agglutination with ristocetin were not significantly altered in RIIIS/J mice. Also, platelets from RIIIS/J mice had normal serotonin content and normal numbers of dense granules by electron microscopy. Thus, the bleeding abnormality is not due to platelet storage pool deficiency as has been found in several other mouse mutants. The activated partial thromboplastin time (APTT) with plasma from RIIIS/J mice was prolonged compared with normal mice, and factor VIII:C activity and von Willebrand antigen levels were one half to one third that of normal mouse ON WILLEBRAND disease (vWD) is considered to be V among the most common of the inherited human bleeding disorders with prevalence as high as 1% in some populations.' It is heterogenous in regard to genetic transmission, clinical and laboratory manifestations, and underlying mechanisms. However, all forms of the disease involve alterations in the structure, function, or concentration of the von Willebrand factor (vWF) protein antigen, which is required for the normal adhesion of platelets to subendothelium.* Fatal bleeding is unusual but does occur.3 Therapy is with blood components or with desmopressin (DDAVP).
Coagulation tests. The activated partial thromboplastin time (APTT) was performed using a commercially available activator (Organon-Technica, Durham, NC). Briefly, 100 pL of citrated mouse platelet-poor plasma (PPP) was incubated with 100 pL of activator for 5 minutes. Recalcification was with 100 pL of 0.2 mol/L CaCI,. Clot endpoint detection was in a photo-optical instrument (American Labor, Largo, FL). The prothrombin time (PT) was performed using a commercially available thromboplastin (Dade, Aguada, Puerto Rico). Two hundred microliters of reagent was added to 100 pL citrated mouse PPP with endpoint detection in the photo-optical system.
Factor assays were performed using either a commercially available human standard (George King, Kansas, MO) calibrated against the second international standard 87/718 for assays of factor VIIIC and vWF, or a pooled mouse standard composed of pooled plasma from eight normal mice. Values for the human standard (American Bioproducts, Parsippany, NJ) were either those supplied by the vendor or those obtained by calibration. Values for the mouse standard were arbitrarily assigned 100 U/dL. Therefore, test plasma results were expressed as units per deciliter. Factor VIIIC was measured using both a chromogenic' and a one-stage chronometric assay. Factor X was assayed using a chromogenic method with Russell Viper venom as activator' for mouse assays against human standard and a one-stage chronometric method for assays against mouse standard. Factors V, IX, XI, and XI1 were all assayed using one-stage chronometric assays," and human substrate plasma was used in all such assays. vWF was assayed by enzyme immunoassay (American Bioproducts).
Mice were killed by anoxia with CO,, and blood was collected by heart puncture. For differential cell counts, blood was collected via a 1-mL syringe with a 22-gauge needle and was immediately placed into EDTA-lined tubes. For all other studies blood was collected into a syringe containing sodium citrate so that the final concentration of sodium citrate was 0.38%. For electron microscopic analysis of platelets, blood samples were centrifuged at l5Og and the supernatant, platelet-rich plasma (PRP), was collected. For plasma factor studies, blood samples were centrifuged at 1,OOOg. and PPP was collected, aliquoted, and frozen at -7OOC. For serotonin assays, citrated blood samples were diluted to 3 mL with 0.85% sodium chloride according to Holland." Blood was subsequently centrifuged at l50g to give PRP. Platelets were collected by centrifugation at 1,OOOg and stored frozen until assay.
Platelets were lysed in distilled water and assayed fluorometrically for serotonin according to Crosti and Luchelli." For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From Electron microscopy. Unfixed and unstained platelets were rap idly air-dried on carbon-coated grids according to Hui and Costa.13 Grids were examined using a Hitachi H-600 transmission electron microscope (Hitachi Instruments, Santa Clara, CA) at 50 kV accelerating voltage, and platelets were photographed at 12,000-fold magnification. The number of dense granules larger than 50 nm were counted in individual platelets.
Platelets were examined by whole blood aggregometry in the Chrono-Log Whole Blood Aggregometer (Model 500, Chrono-Log, Havertown, PA) as described by Novak et al?
For the dose-response curve, DDAVPI4 was diluted with sterile saline and 0.1 mL was injected intraperitoneally into female mice to give doses of 0 to 3 pg/kg. Bleeding times were determined after 60 minutes.
For the time course experiment, DDAVP at 3 pg/kg was injected into individual male and female mice. Bleeding times were determined for three separate mice at each time point.
Sodium dodecyl sulfate (SDS)-agarose gels were used as described by Ruggeri and Zimmerman." Gels were poured onto a glass plate (18 x 14 cm) and were 1 mm thick. The stacking gel was 0.8% agarose in 0.125 mol/L tris buffer, pH 6.8, containing 0.1 % SDS, and the separating gel was 1.5% agarose in 0.375 mol/L tris, pH 8.8 with 0.1% SDS. Gels were run as describedI5 except that electrophoresis was for 12 hours at 12 mA/gel. After electrophoresis the proteins were transferred to nitrocellulose (pore size 0.1 pm) with 0.025 mol/L Tris, 0.2 mol/L glycine, pH 8.8 containing 0.1% SDS and 10% methanol as transfer buffer. Transfer was accomplished in a Hoefer Scientific Instruments (San Francisco, CA) blotting apparatus at 300 mA for 2 hours using cold tap water as a coolant. Nonspecific binding sites on the nitrocellulose were blocked with 50 mmol/L Tris-HCI, pH 7.4, containing 0.5 mol/L NaCl and 5% nonfat dry milk for 1 hour. The nitrocellulose membrane was then incubated with a 1/100 dilution of rabbit antihuman factor VIII-related antigen (Accurate Chemical and Scientific Corp, Westbury, NY) IgG in the same solution for 6 to 12 hours. The membrane was then washed with blocking solution for % hour. The filter was incubated with peroxidaseconjugated goat antirabbit immunoglobulin G (Kirkegaard and Perry Labs, Inc, Gaithersburg, MD) for 6 hours and was stained for peroxidase activity with 4-chloro-I-naphthol plus H,02
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RESULTS
To determine the incidence of bleeding abnormalities among inbred mouse strains, bleeding times were determined for 25 common strains ( Table 1 ). All strains except RIIIS/J had normal (1 to 5 minutes) bleeding times. Also, no differences were noted in bleeding times between the two sexes in any strain.
Thirteen mice of the RIIIS/J inbred strain had, without exception, prolonged bleeding times (1 15 minutes) ( Table  1 ). The abnormal bleeding times were found in both males and females and in mice of widely varying ages (5 weeks to 8 months). We have extended the bleeding time observations (not shown) to 20 minutes for three RIIIS/J mice and found that bleeding continued unabated. Bleeding times in F, heterozygous offspring were mixed (Table 2) ; ie, both long and short bleeders were noted. This was true in both the RIIIS/J x C57BL/6J and the reciprocal C57BL/6J x RIIIS/J cross. More importantly, male offspring of both reciprocal crosses exhibited mixed bleeding times, a result indicating the bleeding trait is inherited autosomally.
Several common hematologic parameters were compared in normal and RIIIS/J mice ( Table 3) . Counts of platelets and red blood cells (RBCs) as well as mean cell volumes were equivalent in normal and RIIIS/J mice. There was a slight increase in hemoglobin concentrations in RIIIS/J. White blood cell (WBC) counts were reduced to half the normal numbers in RIIIS/J.
Coagulation factors were measured relative to a pooled human standard plasma (Table 4 ) and a pooled mouse standard plasma (Table 5) . Several parameters commonly altered in human vWD were likewise abnormal in the RIIIS/J mouse (Tables 4, 5, and 6). The APTT was increased 2.5-fold, and factor VIII:C, measured chromogenically and chronometrically, and plasma vWF antigen concentrations were one half to one third the level found in normal mouse plasma. Plasma levels of vWF were reduced in both male and female (not shown) RIIIS/J mice. On the other For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From hand, platelet vWF (vWFAg) concentrations did not differ between normal mice and RIIIS/J. Prothrombin times, factor IX, and factor X levels were also similar. There was a slight increase in factor V levels in RIIIS/J plasma in plasma from a group of mice measured against a human standard plasma (Table 4) , although this small increase was not apparent in a separate group of mice measured against a pooled mouse plasma ( Table 5 ). There was also a slight decrease in factor XI1 levels in RIIIS/J plasma measured versus a pooled mouse plasma ( Table 5 ), but this degree of reduction did not occur in a second group of RIIIS/J mice ( Table 4) . A more significant and reproducible effect was observed on levels of factor XI, which was at 42% ( Table 4) and 64% (Table 5 ) of normal levels when measured versus a pooled mouse and pooled human standard, respectively. To partially determine the mode of inheritance of the lowered vWF:Ag in RIIIS/J, relative plasma levels of vWF:Ag were determined in heterozygous F, offspring of a cross between normal C57BL/6J and RIIIS/J (Table 6 ). F, progeny and RIIIS/J parents had virtually identical levels of vWFAg, and as described in Tables 4 and 5, C57BL/6J plasma contained approximately twice these levels.
Because a large number of previously characteri~ed'~~~.'' mouse mutants with prolonged bleeding times have platelet storage pool deficiency, the contents of a typical dense granule component, serotonin, and the morphologic appearance of platelet dense granules were determined in RIIIS/J.
Assay values are expressed as units per deciliter using a mouse reference plasma (derived by combining the plasma from eight male C57BL/6J (normal mice) as standard. These assays were performed on a group of five normal and five RIIIS/J mice separate from those used in Table 4 . Values are the mean f SEM. * P I ,001. t P I .05. $ P I .01.
Platelet serotonin concentrations (2.1 pg/ io9 platelets) were within the range found in five other mouse strains with normal bleeding times (Table 7) . When platelets that had been adsorbed to and dried on a grid were examined in the electron microscope, normal numbers of normal appearing dense granules were evident (not shown). The number of dense granules per platelet in RIIIS/J mice was less than in platelets of C57BL/6J (mean of 7 v 1 1 dense granules, respectively) (Fig I) . Some subclasses of human vWD have characteristically abnormal platelet aggregation while other subclasses are normal.* We found little or no diminution in platelet aggregation or adenosine triphosphate (ATP) release when whole blood samples from RIIIS/J were exposed to 4 pg/mL collagen (Fig 2) . Use of lower (1 pg/mL) collagen concentrations showed no significant differences in platelet aggregation between RIIIS/J and C57BL/6J (not shown). Likewise, ristocetin at 1.5 mg/mL caused near-normal agglutination of For (Fig 2B) as did lower (0.75 and 0.38 mg/mL) ristocetin concentrations (not shown).
RIIIS/J platelets
Another characteristic of human vWD is that bleeding times are shortened by administration of DDAVP, which is thought to release vWF from endothelial cells.I4 RIIIS/J mice were found to be responsive to DDAVP (Fig 3) . At higher DDAVP doses (0.9 and 3 pg/kg) the majority or all of the bleeding times returned to normal values (t5 minutes). Partial responses were noted at lower doses. Because the 3 pg/kg dose gave the most consistent response, it was chosen to determine a time course of the response. A clear sex difference was noted in this experiment (Fig 4) . The bleeding times of all females were reduced to normal levels at .75, 1, and 1.5 hours after drug administration. This reduction in bleeding time was partially retained in females at 2 and 3 hours, although most had returned to long bleeding times at 4 and 5 hours. In contrast, a comparatively large number of males exposed to DDAVP had no reduction in bleeding time. This was especially true during the early (up to 1.5 hours) times after DDAVP, though a partial response occurred in males at later times.
A definitive diagnostic feature of normal von Willebrand protein is that it exists in plasma as a series of high-molecularwsight multimers that can be visualized after electrophoresis of plasma on nonreducing SDS g e k 2 A comparison of normal (C57BL/6J) and RIIIS/J plasma by this technique showed (Fig 5) that all normal multimers were present and were in normal proportions in RIIIS/J plasma, although they were uniformly reduced in amount. This result was reproducible in six separate experiments. Also, similar results were obtained when a second antibody labeled with 12sI,18 rather than peroxidase, was used (not shown).
DISCUSSION
While many mouse mutants with pigment diluting genes have increased bleeding prolonged bleeding times are not as commonly observed among other inbred mouse strains as evidenced by the fact that only 1 in 25 strains tested had protracted bleeding on experimental injury. The characteristics of the prolonged bleeding time associated with this one strain, RIIIS/J, indicate that it is an appropriate animal model for human vWD. These include a prolonged APTT, decreased factor VII1:C and factor VII1:Chr activities, and decreased plasma vWF antigen levels. Analysis of plasma for vWF multimers showed that the RIIIS/J strain is, more precisely, a model for human type I v W D .~ That is, all multimers were present and were uniformly reduced in amount. Also, it belongs to the platelet normal subgroup of type la since platelet vWF levels are normal. Type Ia disease includes the majority of human patients with v W D .~ It is interesting that the incidence of type I vWD among inbred mouse strains (1 in 25) is similar to the high 1% incidence rate recently reported for human type I disease.' A very high incidence of type I disease also occurs in the d~g .~. '~ The reduction in factor VII1:C activity and von Willebrand antigen as measured by the immunologic assay is relatively mild, with RIIIS/J mice having 30% to 50% normal levels. This level is sufficient to maintain normal platelet agglutination to ristocetin. The RIIIS/J mouse also has significantly decreased levels of factor XI. Concentrations of factors V, IX, and XI1 were normal or near normal. The prolonged APTT is consistent with the deficiencies of factors XI and VIII. Although mild deficiencies of factor XI are usually not ~ymptomatic,'~ Tavori et alZ0 have noted that patients with mild factor XI deficiency are more likely to manifest a bleeding tendency if they also have vWF abnormalities. Other hematologic properties known to affect bleeding time, such as platelet counts and platelet function, were normal. Platelet serotonin concentrations, the number and visibility of platelet dense granules in the electron microscope, and the amount of ATP released by collagen treatment were within the normal range. In these respects, the bleeding abnormality in the RIIIS/J strain is unlike that in all other mouse mutations thus far de~cribed'.'~ that exhibit platelet storage pool deficiency. Another characteristic of all previously described mouse mutations with bleeding abnormalities is an associated pigment dilution. It is uncertain if a similar dilution gene is present in the RIIIS/J strain because it carries the unrelated albino gene, which would mask the effect of any dilution gene on coat or eye color. An additional difference between the RIIIS/J strain and the normal C57BL/6J strain is the twofold lowering of the WBC count in RIIIS/J. Russell and Bernstein2' have emphasized that total and differential leukocyte counts vary markedly among inbred mouse strains. In fact, several strains such as sublines of the C3H and St strains, which have, like RIIIS/J, low leukocyte counts:' have normal bleeding times ( Table 1) . Therefore, this strongly suggests that the low leukocyte count observed in RIIIS/J mice does not contribute to their prolonged bleeding time.
The prolonged bleeding time in human von Willebrand patients is reduced by infusion of DDAVP." Infusion results in a rapid rise of vWFAg and FVIII:C, with persistent activity for 6 or more hours in humans. The time course of decreased bleeding of female RIIIS/J mice was very similar. An interesting finding was that female mice are considerably more responsive to DDAVP than are males. To our knowledge no comparable finding has been reported in humans. However, it is known that during pregnancy there is an increase in both factor VIII:C and vWF2' and there is often a concomitant improvement in the bleeding time. We have found no significant difference in plasma levels of vWF antigen between males and females of either normal mice or of RIIISIJ mice. The explanation of the difference in response of the sexes to DDAVP remains unknown. Finally, we have found (Novak EK, Swank RT: unpublished results, March 1989) that the long bleeding times in two mouse mutants with platelet storage pool deficiency, pale ear, and ruby-eye,'6 unlike the results with RIIIS/J, are not significantly diminished by treatment with DDAVP.
These studies provide a partial genetic analysis of the bleeding abnormality in RIIIS/J. It is highly likely that the gene(s) causing the bleeding abnormality in RIIISIJ is present in the homozygous condition because of the nature of construction of inbred mouse strains. The RIIIS/J strain has been brother x sister mated for more than 60 generations, so that it is extremely likely that any particular locus is homozygous. Results of reciprocal crosses indicate the bleeding trait is autosomally inherited. In addition, the trait is transmitted with incomplete dominance as evidenced by the mixed bleeding times of heterozygous progeny. The F, progeny are genetically identical because they were derived from homozygous parents. Variable expression among genet- Analyses of plasma vWF antigen canantrations in F, heterozygous mice indicated values identical to those in the affected RIIIS/J parent rather than values intermediate to those of the two parents. This is an interesting result in that it suggests that the genetic alteration affecting vWF levels in RIIIS/J mice involves a regulatory gene rather than a defect in the structural gene for the vWF. Regulatory genes are distinguished by their effects on the synthesis of specific proteins and can give dominant or recessive effects in heterozygous offspring." If the alteration were in the structural gene (the DNA sequence including the amino acid sequence of the von Willebrand protein), it would be expccted that the von Willebrand antigen levels in the hetemygous offspring would be intermediate to those of the two parents.?' because the product of only one chromosome is affected. Other examples of regulatory effects on the vWF are the influences of the A B 0 blood groups"" and the secretor locus." Studies to determine the factor XI levels of F, and backcross mice are in progress.
A r a n t studym has demonstrated that combined factor XI and vWF deficiencies are frequent, at least in the Israeli Jewish population. Of 212 patients with factor XI deficiency, 54 (25%) had combined factor X I and ~WFdeficiency. That combined factor X I and vWF deficiency is prevalent in an ethnic group indicates that the combined deficiency may k genetically controlled. It is known that the structural genes for factor XI and vWF arc unlinked in humans. The factor X I gene is located on the distal end of the long arm of human chromosome 4."' The vWF gene is on the short arm of chromosome 12."-" Therefore. they are not in a gene cluster 
